The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of neoadjuvant therapy with disitamab vedotin plus toripalimab in treating muscle invasive urothelial bladder cancer followed by selective bladder-preserving or radical cystectomy.
 
ZHENYU OU
No Relationships to Disclose
 
Jiao Hu
No Relationships to Disclose
 
Minfeng Chen
No Relationships to Disclose
 
Yangle Li
No Relationships to Disclose
 
Xiongbing Zu
No Relationships to Disclose